XOMA Corporation is a biotechnology company focused on the discovery and development of innovative therapeutic candidates, primarily through a unique royalty aggregation model. Based in Emeryville, California, XOMA partners with biopharmaceutical companies to advance treatments across various disease areas, leveraging its expertise in antibody development and programs with clinical and regulatory validation. The company operates internationally, with strategic interests spanning the United States, Europe, and the Asia Pacific region, positioning itself as a key player in the evolving biotech landscape.